Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Nursing Evaluation01:15

Nursing Evaluation

The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
Section...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulation training in radiation oncology.

Journal of applied clinical medical physics·2025
Same author

Linac-Based Radiosurgery Treatment for a Pineal Parenchymal Tumor.

Cureus·2025
Same author

Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brain.

NPJ Parkinson's disease·2024
Same author

Stereotactic Optimized Automated Radiotherapy (SOAR): a novel automated planning solution for multi-metastatic SRS compared to HyperArc™.

Biomedical physics & engineering express·2024
Same author

Can machine learning models improve early detection of brain metastases using diffusion weighted imaging-based radiomics?

Quantitative imaging in medicine and surgery·2023
Same author

Automated Patch Clamp Screening of Amiloride and 5-<i>N</i>,<i>N</i>-Hexamethyleneamiloride Analogs Identifies 6-Iodoamiloride as a Potent Acid-Sensing Ion Channel Inhibitor.

Molecular pharmaceutics·2023

Related Experiment Video

Updated: Jul 3, 2026

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
06:08

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments

Published on: May 26, 2019

Evaluation of linear accelerator performance standards using an outcome oriented approach.

Alejandra Rangel1, Nicolas Ploquin, Ian Kay

  • 1Department of Medical Physics, Tom Baker Cancer Centre, 1331-29 St NW, Calgary T2N 4N2, Canada. alejrang@cancerboard.ab.ca

Medical Physics
|July 25, 2008
PubMed
Summary
This summary is machine-generated.

Quality control for linear accelerators is crucial for radiation therapy. This study found that while current Canadian guidelines maintain dose deviations within acceptable limits, the impact varies significantly across different performance metrics.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ &alpha; and &beta; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: Jul 3, 2026

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
06:08

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments

Published on: May 26, 2019

Irradiator Commissioning and Dosimetry for Assessment of LQ &alpha; and &beta; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Quality Assurance

Background:

  • Evidence-based practice is increasingly important in radiation therapy to optimize resource allocation.
  • Advancements in treatment technology necessitate robust quality assurance (QA) for equipment and processes.
  • Evaluating QA tolerance levels based on predicted clinical impact is becoming more critical.

Purpose of the Study:

  • To assess the appropriateness of recommended quality control (QC) tolerance and action levels for linear accelerators.
  • To quantify the dosimetric impact of suboptimal linear accelerator performance using the equivalent uniform dose (EUD) as an outcome surrogate.
  • To evaluate these impacts within the tolerance and action levels set by the Canadian Association of Provincial Cancer Agencies (CAPCA).

Main Methods:

  • Simulated linear accelerator performance deviations for prostate, breast, lung, and brain cancer treatments using 3D conformal radiotherapy.
  • Quantified dosimetric changes by calculating alterations in the EUD for target volumes and critical organs at risk (OARs).
  • Examined eight key performance characteristics: output constancy, beam flatness, gantry/collimator angles, field size indicator, laser alignment, and optical distance indicator.

Main Results:

  • Current CAPCA tolerance levels generally maintain average EUD deviations within 2% for targets and 2 Gy for OARs.
  • Significant variability exists in the dosimetric impact of deviations within the accepted 2% or 2 Gy ranges.
  • The effects of suboptimal performance on EUD differ notably across the evaluated performance characteristics and treatment sites.

Conclusions:

  • While CAPCA tolerance levels ensure overall dose limits are met, they do not guarantee uniform dosimetric impact.
  • A more nuanced approach to QA tolerance levels may be needed, considering the specific clinical impact of each performance characteristic.
  • Objective evaluation of equipment performance against predicted clinical outcomes is essential for effective radiation therapy QA.